PentaBind Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
14
- Latest Deal Type
-
Early Stage VC
- Latest Deal Amount
-
$1.16M
- Investors
-
10
PentaBind General Information
Description
Developer of precision aptamer therapeutics intended to treat unmet diseases. The company uses artificial intelligence and an integrated wet laboratory to design aptamers that can be used to detect and target almost any molecule of interest, enabling the biotechnology industry to develop new products and services for precision medicine, therapeutic design, and continuous monitoring.
Contact Information
Website
www.pentabind.comCorporate Office
- Scale Space, 58 Woodlane
- White City
- London W12 7RZ
- England, United Kingdom
Corporate Office
- Scale Space, 58 Woodlane
- White City
- London W12 7RZ
- England, United Kingdom
PentaBind Timeline
PentaBind Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Early Stage VC | 19-Jun-2025 | $1.16M | Completed | Pre-Clinical Trials | ||
| 9. Accelerator/Incubator | 01-Feb-2025 | Completed | Pre-Clinical Trials | |||
| 8. Seed Round | 15-Oct-2024 | Completed | Pre-Clinical Trials | |||
| 7. Accelerator/Incubator | 01-Jan-2024 | Completed | Pre-Clinical Trials | |||
| 6. Accelerator/Incubator | 14-Sep-2023 | Completed | Pre-Clinical Trials | |||
| 5. Angel (individual) | 09-Jan-2023 | Completed | Pre-Clinical Trials | |||
| 4. Accelerator/Incubator | 01-Jan-2023 | Completed | Pre-Clinical Trials | |||
| 3. Accelerator/Incubator | 01-Jan-2023 | Completed | Pre-Clinical Trials | |||
| 2. Accelerator/Incubator | 24-Mar-2022 | $114K | $114K | Completed | Pre-Clinical Trials | |
| 1. Accelerator/Incubator | Completed | Pre-Clinical Trials |
PentaBind Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed Preferred | ||||||||
| A Ordinary | ||||||||
| Seed Preferred | ||||||||
| A Ordinary | ||||||||
| A Ordinary | ||||||||
| A Ordinary | 93,300 | $0.000100 | $1.29 | $1.29 | 1x | $1.29 | 5.85% | |
| A Ordinary | 6,438 | $0.000100 | $9.78 | $9.78 | 1x | $9.78 | 0.4% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
PentaBind Signals
PentaBind Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Hoxton Ventures | Venture Capital | Minority | ||
| Grow London | Accelerator/Incubator | |||
| Next Sequence | Accelerator/Incubator | Minority | ||
| Twin Path Ventures | Venture Capital | Minority | ||
| BioIndustry Association | Accelerator/Incubator |
PentaBind FAQs
-
When was PentaBind founded?
PentaBind was founded in 2021.
-
Where is PentaBind headquartered?
PentaBind is headquartered in London, United Kingdom.
-
What is the size of PentaBind?
PentaBind has 14 total employees.
-
What industry is PentaBind in?
PentaBind’s primary industry is Drug Discovery.
-
Is PentaBind a private or public company?
PentaBind is a Private company.
-
What is the current valuation of PentaBind?
The current valuation of PentaBind is .
-
What is PentaBind’s current revenue?
The current revenue for PentaBind is .
-
How much funding has PentaBind raised over time?
PentaBind has raised $2.48M.
-
Who are PentaBind’s investors?
Hoxton Ventures, Grow London, Next Sequence, Twin Path Ventures, and BioIndustry Association are 5 of 10 investors who have invested in PentaBind.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process